Capital Wealth Planning’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-246,601
| Closed | -$5.44M | – | 160 |
|
|
2024
Q4 | $5.44M | Buy |
246,601
+20,016
| +9% | +$441K | 0.05% | 38 |
|
|
2024
Q3 | $4.08M | Buy |
226,585
+65,235
| +40% | +$1.18M | 0.04% | 45 |
|
|
2024
Q2 | $2.62M | Buy |
161,350
+7,620
| +5% | +$124K | 0.03% | 62 |
|
|
2024
Q1 | $2.17M | Buy |
+153,730
| New | +$2.17M | 0.02% | 62 |
|
|
2021
Q3 | – | Sell |
-23,400
| Closed | -$232K | – | 135 |
|
|
2021
Q2 | $232K | Sell |
23,400
-5,000
| -18% | -$49.6K | 0.01% | 115 |
|
|
2021
Q1 | $328K | Hold |
28,400
| – | – | 0.01% | 91 |
|
|
2020
Q4 | $356K | Sell |
28,400
-4,800
| -14% | -$60.2K | 0.01% | 77 |
|
|
2020
Q3 | $299K | Buy |
33,200
+300
| +0.9% | +$2.7K | 0.01% | 81 |
|
|
2020
Q2 | $406K | Buy |
32,900
+2,313
| +8% | +$28.5K | 0.02% | 77 |
|
|
2020
Q1 | $275K | Buy |
+30,587
| New | +$275K | 0.02% | 174 |
|
|
2019
Q4 | – | Sell |
-28,687
| Closed | -$234K | – | 235 |
|
|
2019
Q3 | $234K | Buy |
28,687
+6,900
| +32% | +$56.3K | 0.01% | 221 |
|
|
2019
Q2 | $201K | Buy |
+21,787
| New | +$201K | 0.01% | 235 |
|